EF-1502 is a GABA reuptake inhibitor. It could potentially be used to treat seizures.
EF-1502 has been shown to inhibit the type 1 GABA transporter (GAT1) and the sodium and chloride-dependent betaine transporter (BGT-1).
Tests in mice have shown that this compound possesses and anticonvulsant effect due to its GABA reuptake inhibiting properties.